Sim&Cure

We’re proud to announce a €3.1M fundraising round to accelerate our mission of transforming endovascular procedures through Digital Twin and AI technologies! This investment—backed by IRDI Capital Investissement, SWEN Capital Partners, Elaia Partners, and Holnest—will help us: 🌍 Expand our global footprint, especially in the Asia-Pacific region 🧠 Develop new innovations to support neurovascular care 🇺🇸🇪🇺 Accelerate commercialization across the US and EMEA Every year, hundreds of thousands of patients suffer from cerebral aneurysm ruptures—with devastating personal and economic impacts. At Sim&Cure, we're addressing this challenge head-on by providing preventive, personalized treatment planning tools that help clinicians make data-driven decisions before entering the cathlab. With Sim&Size™, our flagship software, nearly 30,000 patients have already benefited from improved treatment planning across 46+ countries. A huge thank you to our incredible team, our visionary investors, and our clinical partners who believe in our mission to make neurovascular care safer, smarter, and more accessible. Want to learn more about what’s next? Read the full press release below 👇 #Neurovascular #MedTech #HealthcareInnovation #Fundraising

🎬 End of SLICE Next Frontiers 2025! As we wrap up this incredible event, we want to take a moment to express our deepest gratitude to everyone who made it a success: First and foremost, a huge thank you to all our speakers and participants: 🥼 : Vincent Costalat, Xavier BARREAU, David Altschul, Jacques THÉRON, Saruhan Cekirge, René Chapot, Robert Fahed, Vipul Gupta, Liyong SUN, Professor Tufail Patankar, Aymeric Rouchaud, Adnan Siddiqui, MD, PhD, Laurent SPELLE, Ajay K Wakhloo, MD PhD FAHA FSNIS, Mario Martínez-Galdámez, MD,FEBNI, J Mocco, Luis Savastano, Allison STRICKLAND, Anne Ducros. All the CHU de Limoges team. Your expertise, passion, and engagement have sparked inspiring conversations and elevated the quality of our sessions. We also want to express our appreciation to our wonderful partners and endorsements for their continued support and collaboration. Stryker Neurovascular Medtronic Balt Group Terumo Neuro WallabyPhenox Penumbra, Inc. Johnson & Johnson MedTech Q'Apel Medical Philips Sim&Cure Siemens Healthineers ASAHI INTECC Europe B.V. Sonorous Neurovascular Artiria Medical EndoStream Medical Accumedical Kaneka North America ANZSNR | PAIRS Neuro MEA | STNI | European Society of Neuroradiology | SBNR | ESMINT Society | AINR - Associazione Italiana di Neuroradiologia | European Stroke Organisation | PAIRS Annual Congress | Chinese Stroke Association A heartfelt thank you to all the technical teams who worked tirelessly behind the scenes to ensure everything ran smoothly and seamlessly throughout the event. We couldn't have done it without you all! 🙏 Thank you to everyone who joined us live, and for all the contributions and insights shared during these two exciting days.

Flow Diversion – Pushing the Limits! 🚨 How reliable is flow diversion in the distal vasculature? Do we have enough data? Do we have the right material? Our experts break down the latest evidence and real-world applications. 🧑⚕️Aymeric Rouchaud Adnan Siddiqui, MD, PhD Ajay K Wakhloo, MD PhD FAHA FSNIS Vincent Costalat Liyong Sun Jacques Théron Olivier Babeau Federico Cagnazzo And From the angio-room Laurent SPELLE David Altschul 🔍 Join the discussion and see how far we can go! https://lnkd.in/dUtX3X-h

What are the 12 Academy members doing at SLICE? They’re not just watching—they’re doing! 🚀💡 Selected among all the applicants , they dive into exclusive hands-on sessions by SLICE Workshops, working side by side with our top faculty. From theory to practice, they get real, immersive experience at the heart of the event. 🎟️ VIP access, backstage moments, and high-level learning—this is SLICE Academy Thibault Agripnidis Esteban Loncharic Mukesh Kumar Simone Zilahi De Gyurgyokai Kristian Karlović Teodora Sakelarova Rares Cristian Filep

We’re proud to have taken part in the inspiring ANZSNR 2025 Annual Scientific Meeting in Perth, Western Australia! Set against the stunning backdrop of Elizabeth Quay and hosted at the beautiful Ritz Carlton Hotel, this edition of ANZSNR was a true convergence of clinical expertise, innovation, and collaboration. Thank you to the Australian & New Zealand Society of Neuroradiology and the Scientific Committee for putting together such a high-caliber event, bringing together radiologists, trainees, technologists, and industry partners. It was a privilege to attend sessions led by esteemed speakers such as Assoc. Prof. Hal Rice, Dr. Laetitia de Villiers, Dr. Nathan Manning, Dr. Albert Chiu and Dr. Timothy Phillips, and to connect with so many dedicated professionals across the neuroimaging and neurointerventional community. Beyond the conference, this week marked a meaningful milestone for Sim&Cure in the region. Thanks to our strong partnership with Medtronic ANZ, we successfully completed our in-hospital installation at the major site of WA in Perth, SCGH. We extend our sincere appreciation to the hospital department head, INRs team, IT staff, and Siemens representatives for their warm welcome and efficient support. We're also grateful to reinforce our partnerships with Philips, Stryker, Terumo Neuro, Balt and other key collaborators who help bring innovation into clinical practice. The connections formed, knowledge gained, and momentum built this week reaffirm our commitment to supporting the healthcare teams and delivering meaningful impact to patients. 💡 Interested in learning more about our work in the region? Reach out to us here: https://lnkd.in/e3ts_gV4 Li LI #ANZSNR2025 #Neurointervention #Radiology #Partnerships #DigitalHealth #Innovation #Perth #HealthcareTransformation

Our team, Bella Chau & Tony Costa R.T(R)(VI)(MR), had more to enjoy than just the sunshine and palm trees at the 2nd Annual UCSF Neurovascular Symposium at Indian Wells—we were equally energized by the thoughtful talks, engaging discussions, and the inspiring company of passionate minds dedicated to advancing neurovascular care. A huge thank you to the UCSF Department of Radiology & Biomedical Imaging for organizing such a meaningful event, and to Dr. Daniel Raper, Dr. Steven Hetts, and all the speakers for leading insightful sessions on subdural hematomas, TBI, hemorrhagic conditions, tumors, and the ever-important balance between innovation and patient safety. The case presentations sparked dynamic exchanges among physicians, and we especially appreciated Dr. Seon-Kyu Lee’s interactive format, encouraging collaborative thinking from across the community. It was a pleasure connecting with everyone who took the time to share their experiences and perspectives. We’re already looking forward to next time! 💡 For more information about our solutions, don’t hesitate to reach out to us here: https://lnkd.in/e3ts_gV4 #UCSFNeurovascularSymposium #SimAndCure #NeurovascularInnovation #Collaboration #PatientCare #MedicalInnovation

As SFNR 2025 comes to a close, we reflect on an incredible few days of insightful discussions, valuable collaborations, and shared expertise in neuroradiology. This event reinforced the importance of innovation, research, and technology in shaping the future of patient care. A huge thank you to the Société Française de Neuroradiologie (SFNR) and Vincent Costalat for organizing such a seamless and impactful conference, and to all the attendees and speakers who contributed to these meaningful exchanges. The connections made and knowledge gained will undoubtedly drive our continued efforts in advancing the field. We leave SFNR 2025 inspired and energized, looking forward to the exciting developments ahead! Frantz ARMAND Antoni Neves 💡 Want to learn more about our latest initiatives? Reach out to us here: https://lnkd.in/e3ts_gV4 #SFNR2025 #Neuroradiology #Innovation #Collaboration

🚨 In case you missed it—our crowdfunding campaign is LIVE! 🚨 For the first time, you have the opportunity to invest in Sim&Cure and contribute to the advancement of MedTech innovation in cerebral aneurysm treatment. ✅ 400+ hospitals utilizing our technology ✅ 30,000+ patients benefiting from safer, optimized treatments ✅ A global market with strong growth potential Join us in shaping the future of neurology and healthcare innovation. 👉 Learn more and invest today: https://tdgo.co/fyvjdi #InvestInHealthcare #MedTechRevolution #Crowdfunding #AVC #HealthInnovation

🚨 The wait is over—our crowdfunding campaign is LIVE! 🚨 For the first time, you can invest in Sim&Cure and be part of a MedTech revolution that is transforming the treatment of cerebral aneurysms worldwide. ✅ 400+ hospitals already using our technology ✅ 30,000+ patients benefiting from safer, optimized treatment ✅ A global market opportunity with rapid growth potential This is your chance to become a shareholder in a high-impact healthtech company driving the future of neurology. 📢 Don’t miss out—invest today! 👉 https://tdgo.co/fyvjdi #InvestInInnovation #Crowdfunding #MedTech #Neuroscience 

🌟 Behind every seamless Sim&Size experience is a dedicated team committed to client success. In our latest interview, Antoni Neves, the leader of our training & education team, shares how we ensure clients fully leverage the capabilities of Sim&Size 2.0. From smooth installations to personalized training and clinical support, our approach is designed to provide an exceptional experience at every step. “We’re with our clients throughout the entire product life cycle, ensuring they can maximize the impact of Sim&Size 2.0 on their practice.” As we gear up for the U.S. launch of Sim&Size 2.0, we remain focused on delivering unparalleled support to every user. 🎥 Watch the full interview to see how we’re redefining customer support in healthcare innovation: https://lnkd.in/dP5npFMs #SimAndSize2.0 #CustomerSupport #HealthcareInnovation #UserExperience